Endocrine, metabolic and apical effects of in utero and lactational exposure to non-dioxin-like 2,2',3,4,4',5,5'-heptachlorobiphenyl (PCB 180): A postnatal follow-up study in rats.


Journal

Reproductive toxicology (Elmsford, N.Y.)
ISSN: 1873-1708
Titre abrégé: Reprod Toxicol
Pays: United States
ID NLM: 8803591

Informations de publication

Date de publication:
06 2021
Historique:
received: 27 02 2021
revised: 22 04 2021
accepted: 27 04 2021
pubmed: 17 5 2021
medline: 15 12 2021
entrez: 16 5 2021
Statut: ppublish

Résumé

PCB 180 is a persistent and abundant non-dioxin-like PCB (NDL-PCB). We determined the developmental toxicity profile of ultrapure PCB 180 in developing offspring following in utero and lactational exposure with the focus on endocrine, metabolic and retinoid system alterations. Pregnant rats were given total doses of 0, 10, 30, 100, 300 or 1000 mg PCB 180/kg bw on gestational days 7-10 by oral gavage, and the offspring were sampled on postnatal days (PND) 7, 35 and 84. Decreased serum testosterone and triiodothyronine concentrations on PND 84, altered liver retinoid levels, increased liver weights and induced 7-pentoxyresorufin O-dealkylase (PROD) activity were the sensitive effects used for margin of exposure (MoE) calculations. Liver weights were increased together with induction of the metabolizing enzymes cytochrome P450 (CYP) 2B1, CYP3A1, and CYP1A1. Less sensitive effects included decreased serum estradiol and increased luteinizing hormone levels in females, decreased prostate and seminal vesicle weight and increased pituitary weight in males, increased cortical bone area and thickness of tibial diaphysis in females and decreased cortical bone mineral density in males. Developmental toxicity profiles were partly different in male and female offspring, males being more sensitive to increased liver weight, PROD induction and decreased thyroxine concentrations. MoE assessment indicated that the 95

Identifiants

pubmed: 33992733
pii: S0890-6238(21)00064-2
doi: 10.1016/j.reprotox.2021.04.004
pii:
doi:

Substances chimiques

Carcinogens 0
Dioxins 0
Retinoids 0
2,3,4,5,3',4',5'-heptachlorobiphenyl 39635-31-9
PCB 180 52I0CG8IQX
Polychlorinated Biphenyls DFC2HB4I0K

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

109-127

Informations de copyright

Copyright © 2021 The Author(s). Published by Elsevier Inc. All rights reserved.

Auteurs

Sonia Alarcón (S)

Instituto de Bioingeniería, Universidad Miguel Hernández de Elche, Elche (Alicante), Spain; Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.

Javier Esteban (J)

Instituto de Bioingeniería, Universidad Miguel Hernández de Elche, Elche (Alicante), Spain. Electronic address: jesteban@umh.es.

Robert Roos (R)

Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.

Päivi Heikkinen (P)

Environmental Health Unit, Finnish Institute for Health and Welfare (THL), P.O. Box 95, Kuopio, FI-70701, Finland.

Ismael Sánchez-Pérez (I)

Instituto de Bioingeniería, Universidad Miguel Hernández de Elche, Elche (Alicante), Spain.

Annika Adamsson (A)

Research Center for Integrative Physiology and Pharmacology and Centre for Population Health Research, Institute of Biomedicine, University of Turku, Department of Paediatrics, Turku University Hospital, Turku, FI-20520, Finland.

Jorma Toppari (J)

Research Center for Integrative Physiology and Pharmacology and Centre for Population Health Research, Institute of Biomedicine, University of Turku, Department of Paediatrics, Turku University Hospital, Turku, FI-20520, Finland.

Antti Koskela (A)

Department of Anatomy and Cell Biology, Institute of Cancer Research and Translational Medicine, University of Oulu, Oulu, Finland.

Mikko A J Finnilä (MAJ)

Research Unit of Medical Imaging, Physics and Technology, Faculty of Medicine, University of Oulu, Oulu, Finland.

Juha Tuukkanen (J)

Department of Anatomy and Cell Biology, Institute of Cancer Research and Translational Medicine, University of Oulu, Oulu, Finland.

Maria Herlin (M)

Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.

Gerd Hamscher (G)

Institute of Food Chemistry and Food Biotechnology, Justus Liebig University, Giessen, D-35392, Germany.

Heather A Leslie (HA)

Department of Environment and Health, Vrije Universiteit Amsterdam, De Boelelaan 1108, Amsterdam, NL-1081 HZ, The Netherlands.

Merja Korkalainen (M)

Environmental Health Unit, Finnish Institute for Health and Welfare (THL), P.O. Box 95, Kuopio, FI-70701, Finland.

Krister Halldin (K)

Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.

Dieter Schrenk (D)

Food Chemistry and Toxicology, University of Kaiserslautern, Kaiserslautern, D-67663, Germany.

Helen Håkansson (H)

Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.

Matti Viluksela (M)

School of Pharmacy (Toxicology), Department of Environmental and Biological Sciences, University of Eastern Finland, Kuopio, Finland.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH